The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Vertex Pharmaceuticals Incorporated(NASDAQ:VRTX) 
Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regul...
Website: http://www.vrtx.com
Founded: 1989
Full Time Employees: 3,000
Sector: Healthcare
Industry: Biotechnology
Vertex Pharmaceuticals Number of Twitter Followers
Vertex Pharmaceuticals Days Payable Outstanding ttm (DPO)
Vertex Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Vertex Pharmaceuticals Days Inventory Outstanding ttm (DIO)
Vertex Pharmaceuticals Op Cashflow Per Share ttm
Vertex Pharmaceuticals Free Cashflow Per Share ttm
Vertex Pharmaceuticals Cash Per Share ttm
Vertex Pharmaceuticals P/S ratio ttm
Vertex Pharmaceuticals (GAAP) P/E ratio ttm
Vertex Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.